TAVOCEPT
Dead / Cancelled — Cancelled — Section 8 (as of 12 Jul 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77936917
- Registration number
- 4264896
- Mark type
- Stylized text
- Filed
- 16 Feb 2010
- Published for opposition
- 06 Jul 2010
- Registered
- 25 Dec 2012
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatment of cancer
Owner
- BioNumerik Pharmaceuticals, Inc., San Antonio, TX, US
- BioNumerik Pharmaceuticals, Inc., San Antonio, TX, US
- BioNumerik Pharmaceuticals, Inc., San Antonio, TX, US
Prosecution history
- 13 Jul 2019 — NOTICE OF CANCELLATION SEC. 8 EMAILED
- 12 Jul 2019 — CANCELLED SEC. 8 (6-YR)
- 10 Jan 2019 — POST REGISTRATION ACTION MAILED - SEC. 8
- 10 Jan 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Dec 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Dec 2018 — TEAS SECTION 8 RECEIVED
- 25 Dec 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Dec 2012 — REGISTERED-PRINCIPAL REGISTER
- 20 Nov 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Nov 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 16 Nov 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Nov 2012 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Nov 2012 — USE AMENDMENT FILED
- 01 Nov 2012 — TEAS STATEMENT OF USE RECEIVED
- 10 Jul 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED